ResearcherChristian-Albrechts-Universität zu KielNo recent work listed
Steffen Markus Heckl
Matched on ORCID iD 0000-0001-7002-1462; OpenAlex author ID A5047444294. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 2 papers · 2022: none · 2023: 2 papers
Papers 4
- Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2023.1157397↗
- Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarci… Co-author DOI 10.3389/fonc.2023.1160824↗
- Insulin Receptor in Pancreatic Cancer-Crown Witness in Cross Examination. Co-author DOI 10.3390/cancers13194988↗
- Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control. Co-author DOI 10.3390/medsci9030048↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- H. Schäfer · 4 shared papers, 2021–2023 · strength 0.60
- Paper Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver me… DOI 10.3389/fonc.2023.1160824↗
- Paper Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenoca… DOI 10.3389/fimmu.2023.1157397↗
- Paper Insulin Receptor in Pancreatic Cancer-Crown Witness in Cross Examination. DOI 10.3390/cancers13194988↗
- Christoph Röcken · 4 shared papers, 2021–2023 · strength 0.60
- Paper Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver me… DOI 10.3389/fonc.2023.1160824↗
- Paper Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenoca… DOI 10.3389/fimmu.2023.1157397↗
- Paper Insulin Receptor in Pancreatic Cancer-Crown Witness in Cross Examination. DOI 10.3390/cancers13194988↗
- Susanne Sebens · 4 shared papers, 2021–2023 · strength 0.60
- Paper Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver me… DOI 10.3389/fonc.2023.1160824↗
- Paper Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenoca… DOI 10.3389/fimmu.2023.1157397↗
- Paper Insulin Receptor in Pancreatic Cancer-Crown Witness in Cross Examination. DOI 10.3390/cancers13194988↗
- Tina Daunke · 3 shared papers, 2021–2023 · strength 0.47
- Paper Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver me… DOI 10.3389/fonc.2023.1160824↗
- Paper Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenoca… DOI 10.3389/fimmu.2023.1157397↗
- Paper Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing t… DOI 10.3390/medsci9030048↗
- Silje Beckinger · 3 shared papers, 2021–2023 · strength 0.47
- Paper Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver me… DOI 10.3389/fonc.2023.1160824↗
- Paper Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenoca… DOI 10.3389/fimmu.2023.1157397↗
- Paper Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing t… DOI 10.3390/medsci9030048↗
- Sascha Rahn · 2 shared papers, 2023 · strength 0.34
- Paper Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver me… DOI 10.3389/fonc.2023.1160824↗
- Paper Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenoca… DOI 10.3389/fimmu.2023.1157397↗
- Daniela Wesch · 2 shared papers, 2023 · strength 0.34
- Paper Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver me… DOI 10.3389/fonc.2023.1160824↗
- Paper Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenoca… DOI 10.3389/fimmu.2023.1157397↗
- Anna Maxi Wandmacher · 1 shared paper, 2023 · strength 0.16
- Christian P. Pilarsky · 1 shared paper, 2023 · strength 0.16
- Carolin Schneider · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.